Cargando…

A novel COMP mutation in a Chinese family with multiple epiphyseal dysplasia

BACKGROUND: Multiple epiphyseal dysplasia (MED) is a skeletal disorder characterized by delayed and irregular ossification of the epiphyses and early-onset osteoarthritis. At least 66% of the reported autosomal dominant MED (AD-MED) cases are caused by COMP mutations. METHODS: We recruited a four-ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Jiashen, Zhao, Sen, Yan, Zihui, Wang, Lianlei, Zhang, Yuanqiang, Lin, Mao, Yu, Chenxi, Wang, Shengru, Niu, Yuchen, Li, Xiaoxin, Qiu, Guixing, Zhang, Jianguo, Wu, Zhihong, Wu, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251693/
https://www.ncbi.nlm.nih.gov/pubmed/32460719
http://dx.doi.org/10.1186/s12881-020-01040-y
_version_ 1783539006949031936
author Shao, Jiashen
Zhao, Sen
Yan, Zihui
Wang, Lianlei
Zhang, Yuanqiang
Lin, Mao
Yu, Chenxi
Wang, Shengru
Niu, Yuchen
Li, Xiaoxin
Qiu, Guixing
Zhang, Jianguo
Wu, Zhihong
Wu, Nan
author_facet Shao, Jiashen
Zhao, Sen
Yan, Zihui
Wang, Lianlei
Zhang, Yuanqiang
Lin, Mao
Yu, Chenxi
Wang, Shengru
Niu, Yuchen
Li, Xiaoxin
Qiu, Guixing
Zhang, Jianguo
Wu, Zhihong
Wu, Nan
author_sort Shao, Jiashen
collection PubMed
description BACKGROUND: Multiple epiphyseal dysplasia (MED) is a skeletal disorder characterized by delayed and irregular ossification of the epiphyses and early-onset osteoarthritis. At least 66% of the reported autosomal dominant MED (AD-MED) cases are caused by COMP mutations. METHODS: We recruited a four-generation Chinese family with early-onset hip osteoarthritis, flatfoot, brachydactyly, and mild short stature. An assessment of the family history, detailed physical examinations, and radiographic evaluations were performed on the proband and other family members, followed by the performance of whole-exome sequencing (WES). The pathogenicity of the candidate mutation was also analyzed. RESULTS: An AD-MED family with 10 affected members and 17 unaffected members was recruited. The main radiographic findings were symmetrical changes in the dysplastic acetabulum and femoral heads, irregular contours of the epiphyses, a shortened femoral neck, and flatfoot. Lower bone density was also observed in the ankle joints, wrist joints, and knees, as well as irregular vertebral end plates. In the proband, we identified the missense mutation c.1153G > T (p. Asp385Tyr), located in exon 11 of the COMP gene. This mutation was assessed as 'pathogenic' because of its low allele frequency and its high likelihood of co-segregation with disease in the reported family. Sanger sequencing validated the novel heterozygous mutation c.1153G > T (p. Asp385Tyr) in exon 11 of COMP in all affected individuals in the family. CONCLUSIONS: Our results underlined a key role of the Asp385 amino acid in the protein function of COMP and confirmed the pathogenicity of the COMP (c.1153G > T; p. Asp385Tyr) mutation in AD-MED disease. We have therefore expanded the known mutational spectrum of COMP and revealed new phenotypic information for AD-MED.
format Online
Article
Text
id pubmed-7251693
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72516932020-06-04 A novel COMP mutation in a Chinese family with multiple epiphyseal dysplasia Shao, Jiashen Zhao, Sen Yan, Zihui Wang, Lianlei Zhang, Yuanqiang Lin, Mao Yu, Chenxi Wang, Shengru Niu, Yuchen Li, Xiaoxin Qiu, Guixing Zhang, Jianguo Wu, Zhihong Wu, Nan BMC Med Genet Research Article BACKGROUND: Multiple epiphyseal dysplasia (MED) is a skeletal disorder characterized by delayed and irregular ossification of the epiphyses and early-onset osteoarthritis. At least 66% of the reported autosomal dominant MED (AD-MED) cases are caused by COMP mutations. METHODS: We recruited a four-generation Chinese family with early-onset hip osteoarthritis, flatfoot, brachydactyly, and mild short stature. An assessment of the family history, detailed physical examinations, and radiographic evaluations were performed on the proband and other family members, followed by the performance of whole-exome sequencing (WES). The pathogenicity of the candidate mutation was also analyzed. RESULTS: An AD-MED family with 10 affected members and 17 unaffected members was recruited. The main radiographic findings were symmetrical changes in the dysplastic acetabulum and femoral heads, irregular contours of the epiphyses, a shortened femoral neck, and flatfoot. Lower bone density was also observed in the ankle joints, wrist joints, and knees, as well as irregular vertebral end plates. In the proband, we identified the missense mutation c.1153G > T (p. Asp385Tyr), located in exon 11 of the COMP gene. This mutation was assessed as 'pathogenic' because of its low allele frequency and its high likelihood of co-segregation with disease in the reported family. Sanger sequencing validated the novel heterozygous mutation c.1153G > T (p. Asp385Tyr) in exon 11 of COMP in all affected individuals in the family. CONCLUSIONS: Our results underlined a key role of the Asp385 amino acid in the protein function of COMP and confirmed the pathogenicity of the COMP (c.1153G > T; p. Asp385Tyr) mutation in AD-MED disease. We have therefore expanded the known mutational spectrum of COMP and revealed new phenotypic information for AD-MED. BioMed Central 2020-05-27 /pmc/articles/PMC7251693/ /pubmed/32460719 http://dx.doi.org/10.1186/s12881-020-01040-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Shao, Jiashen
Zhao, Sen
Yan, Zihui
Wang, Lianlei
Zhang, Yuanqiang
Lin, Mao
Yu, Chenxi
Wang, Shengru
Niu, Yuchen
Li, Xiaoxin
Qiu, Guixing
Zhang, Jianguo
Wu, Zhihong
Wu, Nan
A novel COMP mutation in a Chinese family with multiple epiphyseal dysplasia
title A novel COMP mutation in a Chinese family with multiple epiphyseal dysplasia
title_full A novel COMP mutation in a Chinese family with multiple epiphyseal dysplasia
title_fullStr A novel COMP mutation in a Chinese family with multiple epiphyseal dysplasia
title_full_unstemmed A novel COMP mutation in a Chinese family with multiple epiphyseal dysplasia
title_short A novel COMP mutation in a Chinese family with multiple epiphyseal dysplasia
title_sort novel comp mutation in a chinese family with multiple epiphyseal dysplasia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251693/
https://www.ncbi.nlm.nih.gov/pubmed/32460719
http://dx.doi.org/10.1186/s12881-020-01040-y
work_keys_str_mv AT shaojiashen anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT zhaosen anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT yanzihui anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT wanglianlei anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT zhangyuanqiang anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT linmao anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT yuchenxi anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT wangshengru anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT niuyuchen anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT lixiaoxin anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT qiuguixing anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT zhangjianguo anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT wuzhihong anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT wunan anovelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT shaojiashen novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT zhaosen novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT yanzihui novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT wanglianlei novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT zhangyuanqiang novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT linmao novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT yuchenxi novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT wangshengru novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT niuyuchen novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT lixiaoxin novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT qiuguixing novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT zhangjianguo novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT wuzhihong novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia
AT wunan novelcompmutationinachinesefamilywithmultipleepiphysealdysplasia